Tirzepatide for Weight Loss in Stockton: Your Complete Guide to Mounjaro & Zepbound

Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist — a medication that activates two key metabolic hormone pathways simultaneously. Unlike semaglutide, which targets only the GLP-1 receptor, tirzepatide also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor. This dual mechanism provides enhanced appetite suppression, improved insulin sensitivity, and greater metabolic regulation. You may know tirzepatide by its brand names: Mounjaro, which is FDA-approved for type 2 diabetes management, and Zepbound, which is FDA-approved specifically for chronic weight management. Both contain the same active ingredient — tirzepatide — but are prescribed for different indications. At A Touch Above MedSpa in Stockton, tirzepatide is administered as a weekly subcutaneous injection as part of our medically supervised weight loss program. Our injections are mixed with B12, which provides an added boost of energy throughout your weight loss journey. Dr. Shailender Singh, MD, who specializes in Obesity Medicine, oversees all tirzepatide treatments to ensure safety and optimal results.

The SURMOUNT clinical trial program — the largest weight management trial series for tirzepatide — demonstrated remarkable results. Participants treated with tirzepatide at the highest dose (15mg) lost an average of 20-25% of their body weight over 72 weeks. This exceeds the results seen with semaglutide in comparable trials, where average weight loss was 15-17%. To put this in perspective, a 220-pound person on tirzepatide might expect to lose 44-55 pounds on average. Over 90% of participants in the SURMOUNT trials lost at least 5% of their body weight, and more than one-third lost over 25%. Beyond weight loss, SURMOUNT data showed significant improvements in cardiometabolic health markers: reduced waist circumference, improved blood pressure, better cholesterol profiles, and improved blood sugar regulation. These benefits make tirzepatide a powerful tool not just for weight loss but for overall metabolic health improvement. At A Touch Above MedSpa, Dr. Singh uses this clinical evidence to guide treatment decisions and set realistic expectations for Stockton patients considering tirzepatide therapy.

Starting tirzepatide at A Touch Above MedSpa begins with a comprehensive consultation with Dr. Shailender Singh. During this visit, your medical history, current medications, BMI, and weight loss goals are reviewed to determine if tirzepatide is the right choice for you. Candidates typically have a BMI of 30 or higher, or a BMI of 27+ with weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol. Dr. Singh evaluates each patient individually, considering factors beyond BMI alone. Treatment begins at a starting dose of 2.5mg weekly, with dose escalation every 4 weeks based on your tolerance and response. The maximum dose is 15mg weekly. This gradual approach minimizes side effects — particularly the nausea and GI discomfort that are most common during the early weeks of treatment. Our Stockton clinic provides ongoing monitoring, dosing adjustments, and support throughout your treatment. We also offer nutritional guidance and lifestyle coaching to help you build sustainable habits that will support your results long after treatment concludes.